Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Solas

Showing results (81-90 of 121) with videos related to

Pageof 13
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 27, 2020
Hydroxychloroquine and azithromycin tolerance in haemodialysis patients during COVID-19 infectionPhilippe Giaime, Maxime Guenoun, Nathalie Pedinielli, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 28, 2019
Simultaneous determination of cytosine arabinoside and its metabolite uracil arabinoside in human plasma by LC-MS/MS: Application to pharmacokinetics-pharmacogenetics pilot study in AML patientsMelanie Donnette, Caroline Solas, Madeleine Giocanti, et al.
British Journal of Clinical Pharmacology|May 23, 2007
Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patientsCaroline Solas, Nicolas Simon, Marie-Pierre Drogoul, et al.
Cancers|November 27, 2021
Kaposi's Sarcoma in Virally Suppressed People Living with HIV: An Emerging ConditionRomain Palich, Alain Makinson, Marianne Veyri, et al.
Nature Communications|October 3, 2018
Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategiesVincent Madelain, Sylvain Baize, Frédéric Jacquot, et al.
The Journal of Antimicrobial Chemotherapy|June 22, 2019
Concentration-response model of rilpivirine in a cohort of HIV-1-infected naive and pre-treated patientsNadège Néant, Caroline Solas, Naïm Bouazza, et al.
British Journal of Clinical Pharmacology|March 18, 2004
Therapeutic drug monitoring of lopinavir/ritonavir given alone or with a non-nucleoside reverse transcriptase inhibitorCaroline Solas, Isabelle Poizot-Martin, Marie-Pierre Drogoul, et al.
Antiviral Research|July 15, 2021
Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2Franck Touret, Jean-Sélim Driouich, Maxime Cochin, et al.
AIDS (London, England)|May 6, 2016
Estimated glomerular filtration rate but not solute carrier polymorphisms influences anemia in HIV-hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapyFarid Kheloufi, Eric Bellissant, Laurent Cotte, et al.
Toxicology Letters|January 31, 2006
Identification by single-strand conformational polymorphism analysis of known and new mutations of the CYP3A5 gene in a French populationSylvie Quaranta, Dany Chevalier, Véronique Bourgarel-Rey, et al.
Pageof 13

Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 27, 2020
Hydroxychloroquine and azithromycin tolerance in haemodialysis patients during COVID-19 infectionPhilippe Giaime, Maxime Guenoun, Nathalie Pedinielli, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 28, 2019
Simultaneous determination of cytosine arabinoside and its metabolite uracil arabinoside in human plasma by LC-MS/MS: Application to pharmacokinetics-pharmacogenetics pilot study in AML patientsMelanie Donnette, Caroline Solas, Madeleine Giocanti, et al.
British Journal of Clinical Pharmacology|May 23, 2007
Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patientsCaroline Solas, Nicolas Simon, Marie-Pierre Drogoul, et al.
Cancers|November 27, 2021
Kaposi's Sarcoma in Virally Suppressed People Living with HIV: An Emerging ConditionRomain Palich, Alain Makinson, Marianne Veyri, et al.
Nature Communications|October 3, 2018
Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategiesVincent Madelain, Sylvain Baize, Frédéric Jacquot, et al.
The Journal of Antimicrobial Chemotherapy|June 22, 2019
Concentration-response model of rilpivirine in a cohort of HIV-1-infected naive and pre-treated patientsNadège Néant, Caroline Solas, Naïm Bouazza, et al.
British Journal of Clinical Pharmacology|March 18, 2004
Therapeutic drug monitoring of lopinavir/ritonavir given alone or with a non-nucleoside reverse transcriptase inhibitorCaroline Solas, Isabelle Poizot-Martin, Marie-Pierre Drogoul, et al.
Antiviral Research|July 15, 2021
Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2Franck Touret, Jean-Sélim Driouich, Maxime Cochin, et al.
AIDS (London, England)|May 6, 2016
Estimated glomerular filtration rate but not solute carrier polymorphisms influences anemia in HIV-hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapyFarid Kheloufi, Eric Bellissant, Laurent Cotte, et al.
Toxicology Letters|January 31, 2006
Identification by single-strand conformational polymorphism analysis of known and new mutations of the CYP3A5 gene in a French populationSylvie Quaranta, Dany Chevalier, Véronique Bourgarel-Rey, et al.
Pageof 13